Healthcare -
Biotechnology - NASDAQ - US
$ 9.33
2.08 %
$ 465 M
Market Cap
-2.55
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Mineralys Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 192 M |
| Operating Income | -192 M |
| Other Expenses | -14.6 M |
| Net Income | -178 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 192.4 | 84.7 | 31.5 | 18.7 | 2.9 |
| Selling, General and Administrative Expenses | 23.8 | 14.3 | 5.2 | 2.4 | 0.5 |
| Research and Development Expenses | 168.6 | 70.4 | 26.2 | 16.3 | 2.4 |
| Operating Income | (192.4) | (84.7) | (31.5) | (18.7) | (2.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0 | 1.7 | 27 K | 0.1 |
| Total Other Income | 14.6 | 12.8 | 1.7 | (0.7) | (0.5) |
| Pre-Tax Income | (177.8) | (71.9) | (29.8) | (19.4) | (3.4) |
| NET INCOME | |||||
| Tax Provision | 0 | 0 | (1.9) | 27 K | 0.1 |
| Net Income | (177.8) | (71.9) | (29.8) | (19.4) | (3.4) |
| EPS | 3.66 | 1.99 | 0.73 | 0.5 | 0.0877 |